PPARA and obesity disorder: Therefore, due to the vital metabolic modulating roles and excellent druggability of PPARs, PPAR agonists and antagonists have been employed for the therapy of a number of diseases, such as dyslipidemia, type 2 diabetes, cardiovascular diseases, obesity, cancer, and other metabolic diseases (22).